Multiple trichoepitheliomas associated with a novel heterozygous mutation in the CYLD gene as an adjunct to the histopathological diagnosis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American journal of dermatopathology

• Publication date

  2013-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/DAD.0b013e31827132afPMID 23694822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ber‐EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms

  2012cited by this paper
• CD10 expression helps to differentiate basal cell carcinoma from trichoepithelioma*

  2011influential reference
• Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.

  2011cited by this paper
• Multiple (Familial) Trichoepitheliomas: A Clinicopathological and Molecular Biological Study, Including CYLD and PTCH Gene Analysis, of a Series of 16 Patients

  2011influential reference
• Recurrent CYLD nonsense mutation associated with a severe, disfiguring phenotype in an African American family with multiple familial trichoepithelioma.

  2011cited by this paper
• PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma

  2011cited by this paper
• Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin‐20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens

  2011influential reference
• p75 Neurotrophin receptor differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma: insights into the histogenesis of adnexal tumours based on embryology and hair follicle biology

  2010cited by this paper
• Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma

  2010cited by this paper
• Spectrum of Tumors With Follicular Differentiation in a Patient With the Clinical Phenotype of Multiple Familial Trichoepitheliomas: A Clinicopathological and Molecular Biological Study, Including Analysis of the CYLD and PTCH Genes

  2009cited by this paper
• Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.

  2009cited by this paper
• Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: a critical reappraisal of histomorphological and immunohistochemical criteria for differentiation

  2008cited by this paper
• Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.

  2008influential reference
• Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?

  2007influential reference
• A novel splicing mutation of the CYLD gene in a Taiwanese family with multiple familial trichoepithelioma

  2007cited by this paper
• CD10 expression in trichoepithelioma and basal cell carcinoma *

  2006influential reference
• Androgen Receptor Expression Helps to Differentiate Basal Cell Carcinoma from Benign Trichoblastic Tumors

  2005cited by this paper
• Proliferative characterization of basal‐cell carcinoma and trichoepithelioma in small biopsy specimens

  2004influential reference
• Expression of p27kip1 in Basal Cell Carcinomas and Trichoepitheliomas

  2002cited by this paper
• An economic method for the fluorescent labeling of PCR fragments

  2000cited by this paper
• Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl‐2, Ki67, PCNA and P53

  2000influential reference
• An immunohistochemical study of basal cell carcinoma and trichoepithelioma.

  1999cited by this paper
• Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma.

  1998cited by this paper
• Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens

  1998cited by this paper
• Transforming Growth Factor‐Beta and bcl‐2 Distribution Patterns Distinguish Trichoepithelioma from Basal Cell Carcinoma

  1997cited by this paper
• The gene for multiple familial trichoepithelioma maps to chromosome 9p21.

  1996cited by this paper
• CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.

  1994influential reference
• Epithelioma adenoides cysticum and solitary trichoepithelioma.

  1963influential reference

• Genetic Testing in CYLD Cutaneous Syndrome: An Update

  2021cites this paper
• TACG_A_288274 427..444

  2021cites this paper
• Trichoepithelioma: A Comprehensive Review.

  2018cites this paper
• The cylindromatosis (CYLD) gene and head and neck tumorigenesis

  2016cites this paper
• Genetic, haplotype and functional investigations on rare monogenic diseases

  2016cites this paper
• Tumor vlasišta - turban tumor sindrom: prikaz slučaja

  2016cites this paper
• Phenotype-genotype correlations for clinical variants caused by CYLD mutations.

  2015cites this paper
• Report of Three Novel Germline CYLD Mutations in Unrelated Patients with Brooke-Spiegler Syndrome, Including Classic Phenotype, Multiple Familial Trichoepitheliomas and Malignant Transformation

  2015cites this paper
• A novel frameshift mutation in the cylindromatosis (CYLD) gene in a Chinese family with multiple familial trichoepithelioma

  2014cites this paper